Back

Targeting cardiomyocyte GBP5 mitigates cardiac inflammatory injury

20 June 2026 (14:45 - 15:00)
Organised by: Logo
Congress Presentation Part of: Novel pathways in CTR-CVT Cancer Biology and Treatment Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Jannek Brauer

University Hospital Heidelberg, Heidelberg (Germany)

1 More presentation in this session

Presentation thumbnail
Doxorubicin induces bone marrow B-cell dysmaturation via Ebf1/Pax5 suppression to drive peripheral B-cell reduction in cardiotoxicity
Doctor S. Zhang (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Novel pathways in CTR-CVT
Video

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 14:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources